Parmax Pharma: Acquirers to gain control via SPA, Open Offer

Parmax Pharma Ltd announced that Dhiren Chandulal Shah and Sunil Chinubhai Shah, along with associated parties, are set to acquire majority control. This will be achieved through a combination of preferential allotment, a share purchase agreement (SPA) with existing promoters (Alkesh Mahasukhlal Gopani, Vipul Mahasukhlal Gopani, Pravina Mahasukh Gopani), and an open offer. The SPA involves the sale of shares at ₹35 per equity share. The acquisition is subject to statutory approvals. Separately, the company is issuing shares at ₹36.50 and convertible warrants at the same price.